Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan;131(1):20-31.
doi: 10.1111/bju.15883. Epub 2022 Sep 27.

Guidelines of guidelines: focal therapy for prostate cancer, is it time for consensus?

Sean Ong  1   2 , Kenneth Chen  3   4 , Jeremy Grummet  5 , John Yaxley  6   7   8 , Matthijs J Scheltema  9   10 , Phillip Stricker  9   10   11 , Kae Jack Tay  4 , Nathan Lawrentschuk  1   2   3   12
Affiliations
Review

Guidelines of guidelines: focal therapy for prostate cancer, is it time for consensus?

Sean Ong et al. BJU Int. 2023 Jan.

Abstract

Objective: To provide a summary and discussion of international guidelines, position statements and consensus statements in relation to focal therapy (FT) for prostate cancer (PCa).

Methods: The European Association of Urology-European Association of Nuclear Medicine-European Society for Radiotherapy and Oncology-European Society of Urogential Radiology-International Society of Urological Pathology-International Society of Geriatric Oncology and American Urological Association-American Society for Radiation Oncology-Society of Urologic Oncology guidelines were interrogated for recommendations for FT. PubMed and Ovid Medline were searched for consensus statements. Only studies in English since 2015 were included. Reference lists of the included articles were also interrogated and a manual search for studies was also performed.

Results: Our results showed a lack of long-term randomised data for FT. International Urological guidelines emphasised the need for more high-quality clinical trials with robust oncological and toxicity outcomes. Consensus and positions statements were heterogenous.

Conclusion: A globally accepted guideline for FT planning, technique and follow-up are still yet to be determined. Well-designed studies with long-term follow-up and robust clinical and toxicity endpoints are needed to improve our understanding of FT and create uniform guidelines to streamline management and follow-up.

Keywords: consensus; focal therapy; guidelines; prostate cancer; prostate carcinoma.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Bates AS, Ayers J, Kostakopoulos N et al. A systematic review of focal ablative therapy for clinically localised prostate cancer in comparison with standard management options: limitations of the available evidence and recommendations for clinical practice and further research. Eur Urol Oncol 2021; 4: 405–23 - PubMed
    1. van der Poel HG, van den Bergh RC, Briers E et al. Focal therapy in primary localised prostate cancer: the European Association of Urology position in 2018. Eur Urol 2018; 74: 84–91 - PubMed
    1. Mottet N, van den Bergh RC, Briers E et al. EAU‐EANM‐ESTRO‐ESUR‐SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 2021; 79: 243–62 - PubMed
    1. Sanda MG, Cadeddu JA, Kirkby E et al. Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. Part I: risk stratification, shared decision making, and care options. J Urol 2018; 199: 683–90 - PubMed
    1. Edward Schaeffer SS, Antonarakis ES, Armstrong AJ et al. NCCN clinical practice guidelines in oncology (NCCN Guidelines®) prostate cancer2022. Version 4.2022:[1–197 pp.]. 2022. Available at: https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf. Accessed 20 July 2022